Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
$17.5 Million in Cash and Marketable Securities as of December 31, 2022; Expected to Support…
News
Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
$17.5 Million in Cash and Marketable Securities as of December 31, 2022; Expected to Support…
Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells
LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…
Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells
LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…
Cidara Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Cidara Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Jasper Therapeutics to Present at Cantor Fitzgerald’s The Future of Oncology Virtual Symposium
REDWOOD CITY, Calif., March 31, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
Jasper Therapeutics to Present at Cantor Fitzgerald’s The Future of Oncology Virtual Symposium
REDWOOD CITY, Calif., March 31, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
TScan Therapeutics Announces CEO Transition
David Southwell steps down; Gavin MacBeath, Ph.D., Chief Scientific and Operating Officer, to serve as…
TScan Therapeutics Announces CEO Transition
David Southwell steps down; Gavin MacBeath, Ph.D., Chief Scientific and Operating Officer, to serve as…
Reflect Scientific Inc Announces Year-End Financial Results for 2022
OREM, Utah, March 31, 2023 (GLOBE NEWSWIRE) — Reflect Scientific Inc (OTCQB: RSCF), a provider…
Reflect Scientific Inc Announces Year-End Financial Results for 2022
OREM, Utah, March 31, 2023 (GLOBE NEWSWIRE) — Reflect Scientific Inc (OTCQB: RSCF), a provider…
Alimera Sciences Announces 2022 Financial Results and Business Update
• 2022 Product Revenue Increased to $54.1 Million, Up 13% over 2021 • Global End User…
Alimera Sciences Announces 2022 Financial Results and Business Update
• 2022 Product Revenue Increased to $54.1 Million, Up 13% over 2021 • Global End User…
Immutep Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023
Media Release Efti plus pembrolizumab achieved mOS of 9.9 months and a 39% OS rate…
Immutep Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023
Media Release Efti plus pembrolizumab achieved mOS of 9.9 months and a 39% OS rate…
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
— Completed business combination with FLAC and closed concurrent, oversubscribed approximately $235 million PIPE, led…
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
— Completed business combination with FLAC and closed concurrent, oversubscribed approximately $235 million PIPE, led…
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
If subsequently approved, Entresto will be the first and only approved therapy for the treatment…
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
If subsequently approved, Entresto will be the first and only approved therapy for the treatment…